Inhibition of ER stress by 4-PBA protects MCT-induced pulmonary arterial hypertension via reducing NLRP 3 inflammasome activation

Meichun Zeng,Wenhua Sang,Xiaoxia Kong,Yu Liu,Shan Chen,Hailin Zhang

Abstract:NLRP3 inflammasome activation and endoplasmic-reticulum (ER) stress contribute to the pathogenesis and development of pulmonary arterial hypertension (PAH). Recently studies have shown that ER stress induced NLRP3 inflammasome activation in chronic liver diseases. But the mechanism is still unclear, especially the role of ER stress and relationship with NLRP3 inflammasome in monocrotaline MCT-induced PAH. To identify the cellular mechanism of ER stress mediate NLRP3 inflammasome during MCT-induced PAH, we investigated the influence of classic ER stress inhibitor 4-phenyl butyric acid (4-PBA) on ER stress and NLRP3 inflammasome, which partially affect the activation of inflammation, PAH was induced by injecting MCT for 4 weeks. The rats were randomly assigned to control group, MCT group, and 4-PBA treatment group. We demonstrated that inhibition of ER stress by 4-PBA, which further prevented the activation of the NLRP3 inflammasome, decreased the release of the pro-inflammatory mediators IL-1β, IL-6 and TNF-α. Moreover, it was found that 4-PBA decreased LPS-induced PAECs injury through decreasing activation of NLRP3 inflammasomes and expression of inflammatory factors. Taken together, our study indicated that inhibition of ER stress by 4-PBA protects the MCT-induced PAH through decreasing activation of NLRP3 inflammasomes and release of pro-inflammatory mediators.

Environmental Science,Medicine